PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Tilray Brands, Inc. (TLRY.TO)
2.000.05 (2.56%)
1.90 - 2.15
0.48 - 2.54
9.88M / 3.06M (Avg.)
-0.59 | -3.40
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
53.38%
Net income growth at 50-75% of CRON.TO's 94.48%. Martin Whitman would worry about lagging competitiveness unless expansions are planned.
6.19%
Less D&A growth vs. CRON.TO's 47.07%, reducing the hit to reported earnings. David Dodd would confirm that core assets remain sufficient.
102.44%
Deferred tax of 102.44% while CRON.TO is zero at 0.00%. Bruce Berkowitz would see a partial difference that can matter for future cash flow if large in magnitude.
-15.99%
Negative yoy SBC while CRON.TO is 4.46%. Joel Greenblatt would see less immediate dilution advantage if talent levels remain strong.
-86.82%
Both reduce yoy usage, with CRON.TO at -138.31%. Martin Whitman would find an industry or cyclical factor prompting leaner operational approaches.
193.94%
AR growth while CRON.TO is negative at -174.17%. John Neff would note competitor possibly improving working capital while we allow AR to rise.
424.16%
Some inventory rise while CRON.TO is negative at -112.10%. John Neff would see competitor possibly benefiting from leaner stock if demand remains.
-203.26%
Both negative yoy AP, with CRON.TO at -140.68%. Martin Whitman would find an overall trend toward paying down supplier credit in the niche.
-109.13%
Both reduce yoy usage, with CRON.TO at -201.05%. Martin Whitman would suspect an industry or cyclical factor pulling back on these items.
-105.49%
Both negative yoy, with CRON.TO at -99.25%. Martin Whitman would suspect an overall environment of intangible cleanup or shifting revaluations for the niche.
-136.34%
Both yoy CFO lines are negative, with CRON.TO at -113.11%. Martin Whitman would suspect cyclical or cost factors harming the entire niche’s cash generation.
66.53%
Some CapEx rise while CRON.TO is negative at -11.27%. John Neff would see competitor possibly building capacity while we hold back expansions.
1535.04%
Acquisition spending well above CRON.TO's 100.00%. Michael Burry would suspect heavier integration risk or short-term free cash flow drain vs. competitor.
-3624.90%
Negative yoy purchasing while CRON.TO stands at 100.00%. Joel Greenblatt sees a near-term liquidity advantage unless competitor’s new investments produce outsized returns.
No Data
No Data available this quarter, please select a different quarter.
-278.96%
Both yoy lines negative, with CRON.TO at -7.85%. Martin Whitman suspects a cyclical or strategic rationale for cutting extra invests in the niche.
-246.65%
We reduce yoy invests while CRON.TO stands at 131.47%. Joel Greenblatt sees near-term liquidity advantage unless competitor’s expansions yield high returns.
89.48%
Debt repayment growth of 89.48% while CRON.TO is zero at 0.00%. Bruce Berkowitz sees a mild advantage that can reduce interest costs unless expansions demand capital here.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.